CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the efficacy of lenvatinib and pembrolizumab to treat metastatic uveal melanoma....
Phase 2
Portland, Oregon, United States
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...
Phase 2
Portland, Oregon, United States and 56 other locations
To evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investig...
Phase 2
Portland, Oregon, United States and 55 other locations
study is to determine the objective response of GB1211 and pembrolizumab versus pembrolizumab and placebo in patients with advance metastatic melanoma...
Phase 2
Portland, Oregon, United States
The purpose of this study is compare the response rates in patients with metastatic melanoma treated with high-dose IL-2 to patients treated...
Phase 2
Portland, Oregon, United States
and feasibility of a humanized OX40 agonist, MEDI0562, in the pre-operative setting for patients with head and neck squamous cell carcinoma or melanoma...
Phase 1
Portland, Oregon, United States
PV-10 in combination with immune checkpoint inhibition. Metastatic melanoma patients (Stage IV or Stage III unresectable, in-transit or sate...
Phase 1, Phase 2
Portland, Oregon, United States and 4 other locations
This is a single arm phase II clinical trial of Ipilimumab and Nivolumab in patients with resected mucosal melanoma. Ipilimumab (1 mg/kg) an...
Phase 2
Portland, Oregon, United States and 6 other locations
and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recur...
Phase 3
Portland, Oregon, United States and 128 other locations
and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants with complete resection of cutaneous melanoma...
Phase 2
Portland, Oregon, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal